(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 4.51% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.34%.
Boston Scientific's revenue in 2026 is $20,996,000,000.On average, 34 Wall Street analysts forecast BSX's revenue for 2026 to be $31,219,302,449,092, with the lowest BSX revenue forecast at $30,007,746,565,356, and the highest BSX revenue forecast at $32,814,904,157,218. On average, 34 Wall Street analysts forecast BSX's revenue for 2027 to be $32,533,753,629,174, with the lowest BSX revenue forecast at $31,177,274,792,838, and the highest BSX revenue forecast at $34,874,259,313,664.
In 2028, BSX is forecast to generate $34,940,923,871,860 in revenue, with the lowest revenue forecast at $32,765,630,353,334 and the highest revenue forecast at $41,569,699,723,784.